Pharma CEOs

Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too
Fierce Pharma
Teva Pharmaceutical
Pharma CEOs
Kåre Schultz
executive pay
Flag link:
Lilly CEO Ricks scores big pay bump to $21.3M, beating out other Big Pharma CEOs
Lilly CEO Ricks scores big pay bump to $21.3M, beating out other Big Pharma CEOs
Fierce Pharma
Eli Lilly
Pharma CEOs
David Ricks
executive pay
Flag link:
Two biotech CEOs test positive for Covid-19 after attending investor conference
Two biotech CEOs test positive for Covid-19 after attending investor conference
MedCity News
Pharma CEOs
Allogene
Apellis Pharmaceuticals
Arie Belldegrun
Cedric Francois
COVID-19
Biogen
Flag link:
CureVac CEO replaced in midst of biotech's coronavirus push
CureVac CEO replaced in midst of biotech's coronavirus push
BioPharma Dive
CureVac
vaccines
COVID-19
Daniel Menichella
Pharma CEOs
Flag link:
Roche CEO Schwan sees his 2019 pay dip by 2% as his European peers get big raises
Roche CEO Schwan sees his 2019 pay dip by 2% as his European peers get big raises
Fierce Pharma
Roche
Pharma CEOs
Severin Schwan
executive pay
Flag link:
GSK’s Walmsley gets £2.5m pay rise after strong 2019
GSK’s Walmsley gets £2.5m pay rise after strong 2019
Pharmaforum
GSK
Emma Walmsley
executive pay
Pharma CEOs
women executives
Flag link:
Merck CEO Frazier finds fault in new studies suggesting pharma profits are too high
Merck CEO Frazier finds fault in new studies suggesting pharma profits are too high
Fierce Pharma
JAMA
profits
Merck
Ken Frazier
Pharma CEOs
Flag link:
Endo Names Blaise Coleman Successor to Retiring CEO Paul Campanelli
Endo Names Blaise Coleman Successor to Retiring CEO Paul Campanelli
Xconomy
Endo International
Pharma CEOs
Paul Campanelli
Blaise Coleman
Flag link:
Sanofi Slims Top Executive Ranks as New CEO Paul Hudson Revamps Strategy
Sanofi Slims Top Executive Ranks as New CEO Paul Hudson Revamps Strategy
Bloomberg
Sanofi
restructuring
Paul Hudson
Pharma CEOs
Flag link:
Myriad Genetics CEO Mark Capone Resigns
Myriad Genetics CEO Mark Capone Resigns
Motley Fool
Myriad Genetics
Mark Capone
Pharma CEOs
earnings
Flag link:
Ian Read adds a new post to his growing roster of post-Pfizer positions — and this one pays well
Ian Read adds a new post to his growing roster of post-Pfizer positions — and this one pays well
Endpoints
Pfizer
Ian Read
Pharma CEOs
Flag link:
Gilead CEO O'Day feels 'sense of urgency' on dealmaking as Kite writedowns add up
Gilead CEO O'Day feels 'sense of urgency' on dealmaking as Kite writedowns add up
Fierce Pharma
Gilead Sciences
Kite Pharma
Daniel O'Day
Pharma CEOs
Flag link:
Merck Has A Great Future, Because It Has A Soul: Ken Frazier
Merck Has A Great Future, Because It Has A Soul: Ken Frazier
Forbes
Ken Frazier
Merck
Pharma CEOs
Flag link:
Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like
Vas Narasimhan wants Novartis to have a big focus on China. Here’s what that looks like
Endpoints
Novartis
China
Pharma CEOs
Vas Narasimhan
Flag link:
Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings
Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings
Fierce Pharma
Merck
Ken Frazier
Pharma CEOs
JPMHC 2020
Gardasil
vaccines
drug manufacturing
Flag link:
Abbott’s Diabetes Device Dominates As CEO White Hands Over Reigns
Abbott’s Diabetes Device Dominates As CEO White Hands Over Reigns
Forbes
Abbott Labs
Miles White
Pharma CEOs
devices
FreeStyle Libre
diabetes
Flag link:
As its Drug Business Sees Growth in 2019, Lonza Continues to Search for New CEO
As its Drug Business Sees Growth in 2019, Lonza Continues to Search for New CEO
BioSpace
Lonza
Pharma CEOs
Marc Funk
Flag link:
JPM: New Novartis pharma chief rethinks its drug-launch formula
JPM: New Novartis pharma chief rethinks its drug-launch formula
Fierce Pharma
Novartis
Pharma CEOs
Vas Narasimhan
drug launches
JPMHC 2020
Flag link:
GSK’s CEO Walmsley aiming for six new approvals in 2020
GSK’s CEO Walmsley aiming for six new approvals in 2020
Pharmaforum
GSK
Pharma CEOs
Emma Walmsley
JPMHC 2020
Zejula
Trelegy
daprodustat
belantamab mafodotin
Flag link:
JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another
JPM kickoff: Gilead's deal ideal, Novartis' image-polishing, Teva's shutdown tally and one CEO's word on another
Fierce Pharma
JPMHC 2020
Teva Pharmaceuticals
Novartis
Gilead Sciences
M&A
Pharma CEOs
Flag link:

Pages